Bionano Genomics (BNGO) vs NexGel (NXGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bionano Genomics is the larger company by market cap ($16.9 million vs $97,622), about 173.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | NXGL |
|---|---|---|
| Share price | $1.44 | $0.2003 |
| Market cap | $16.90M | $97.62K |
| 1-day change | -1.71% | +33.53% |
| YTD return | -6.21% | — |
| 1-year return | -32.63% | — |
| 5-year return | -99.95% | — |
| EPS (TTM) | $-3.02 | $-14.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $57.00 |
| 52-week low | $1.00 | $0.151 |
| Distance from 52-week high | -35.65% | -99.65% |
| Analyst consensus | none | hold |
| Avg. price target upside | +248.43% | — |
| Average volume | 921.59K | 37.86K |
| Shares outstanding | 11.78M | 487.38K |
| Employees | 95 | 19 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Bionano Genomics is about 173.1 times larger than NexGel by market value ($16.90M vs $97.62K).
- The two companies sit in different sectors: Bionano Genomics in Industrials and NexGel in Health Care.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About NexGel
NXGL stock →NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Health Care · Medical/Dental Instruments · 19 employees
BNGO vs NXGL FAQ
Which is bigger, Bionano Genomics or NexGel?
Bionano Genomics (BNGO) is larger, with a market capitalization of $16.90M compared with $97.62K for NexGel (NXGL).
Are Bionano Genomics and NexGel in the same industry?
No. Bionano Genomics is in the Industrials sector, while NexGel is in Health Care.